Smaller proportion of Medicare patients hospitalized for heart problems
Heart-related problems accounted for a smaller proportion of hospitalizations among Medicare beneficiaries within the past ten years than did other causes for hospitalization, researchers reported at the American Heart Association's Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke 2011 Scientific Sessions.
The study, the largest within the past decade to look at hospitalization rates among Medicare beneficiaries, found that the proportion of heart disease hospitalizations is falling at a faster rate than those from other leading causes of hospital admissions.
"We're seeing that common cardiac diseases are accounting for a smaller proportion of hospitalizations within the United States," said Amit H. Sachdev, the study's lead author and a fourth-year medical student at New York University School of Medicine. "We believe this may reflect an improvement in medical care and preventive efforts and in delivering healthcare in the United States over the last decade."
From 1998 to 2008, the proportion of acute care hospitalizations declined for six of the eight leading causes of admissions. Coronary artery disease saw the largest drop, according to the study: 538,749 hospital admissions in 1998 compared to 409,763 in 2008. Heart attack saw the second-largest decline, falling from 358,251 in 1998 to 311,276 by 2008.
Among the most common heart-related conditions, the total proportion of hospital admissions fell:
- 31.7 percent for coronary artery disease;
- 22.2 percent for heart attack;
- 16.8 percent for heart failure; and
- However, the total proportion of hospitalizations for cardiac arrhythmia (irregular heartbeat) increased 10.5 percent.
- 18.9 percent for pneumonia;
- 14.5 percent for fluid and electrolyte disorders;
- 11.6 percent for hip fracture.
Researchers analyzed data from more than 11 million Medicare beneficiaries who were hospitalized for any cause in 1998. The total number of hospitalizations reached roughly 13 million in 2008.
Sachdev said increased government efforts to improve cardiac care may help explain the findings.
"Heart disease is the leading cause of hospitalization in the United States, so you see a lot of government money focused at cardiac conditions," he said.
He cited better diagnostic tests, physicians getting more heart disease education, and more frequent use of medications to prevent or control heart disease.
Calling the findings "informative and encouraging," Sachdev said the next step will be determining why the hospitalization rate is falling for some conditions, and rising for others. Future research must also tease out which specific groups are being affected more or less, he said.
"This study looks at the entire country in one broad-brush stroke," said Sachdev, who is also a research fellow with the Yale/Yale New Haven Center of Outcomes Research and Evaluation where the study was conducted. "Future studies within our research group are going to delve into racial and regional differences in healthcare delivery. Our goal is to ensure quality care and equal care to everyone in the United States,"
Researchers noted the findings can only be applied to an older population that Sachdev said is expected to double in size over the next 15 years.
"You would expect, naturally, that as the size of the population increases, you would get more people being hospitalized," he said. "So, further efforts in therapeutic and preventive interventions must be made to continue to see these declines."
Sachdev recommends patients work closely with their physician to learn how to prevent or manage heart disease. Avoid hospitalization by eating a healthy diet, exercising regularly, taking the right medication and attending regular follow-up appointments with a physician, he said.
Provided by
American Heart Association
-
Heart failure hospitalization rates rise among nation's seniors
Nov 09, 2008 |
not rated yet |
0
-
Tobacco cessation medication may reduce hospitalization for heart attacks
Dec 07, 2010 |
not rated yet |
0
-
Nationwide smoking ban would help reduce heart attack admissions, slash costs
May 20, 2010 |
not rated yet |
0
-
Study identifies factors leading to hospital admission for heart failure
Apr 28, 2008 |
not rated yet |
0
-
Primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life
Jun 05, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
The Durability of Bone: Long Falls
3 hours ago
-
Is energy convertible to matter?
5 hours ago
-
Rotating electron as a dipole is this right?
7 hours ago
-
Dipole term in multipole expansion
11 hours ago
-
Bubbles in a Pre-Boiling/Boiling pot of water
12 hours ago
-
Assumptions of Griffith's fracture theory
23 hours ago
- More from Physics Forums - Classical Physics
More news stories
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
8 hours ago |
5 / 5 (1) |
0
Post-approval TAVI registry shows high rates of device success at one year
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...
Cardiology
8 hours ago |
not rated yet |
0
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Cardiology
9 hours ago |
5 / 5 (1) |
0
|
Study identifies superior hypertension treatment, efficacy between sexes
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...
Cardiology
17 hours ago |
5 / 5 (1) |
0
Evaluating a new way to open clogged arteries
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...
Cardiology
18 hours ago |
4.6 / 5 (5) |
0
|
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.